CONMED (CNMD)
(Delayed Data from NYSE)
$52.29 USD
+1.14 (2.23%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $52.32 +0.03 (0.06%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, CONMED Corporation has a PEG ratio of 1.29 compared to the Medical - Dental Supplies industry's PEG ratio of 1.54.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CNMD 52.29 +1.14(2.23%)
Will CNMD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CNMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CNMD
CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised
Compared to Estimates, Conmed (CNMD) Q2 Earnings: A Look at Key Metrics
CNMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Conmed (CNMD) Q2 Earnings and Revenues Top Estimates
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Other News for CNMD
Decoding Conmed Corp (CNMD): A Strategic SWOT Insight
CNMD Receives Analyst Rating Update: Price Target Lowered by Piper Sandler | CNMD Stock News
Conmed (CNMD) Price Target Adjusted by Piper Sandler Analyst
Conmed price target lowered by $12 at Piper Sandler, here's why
Q2 2025 Conmed Corp Earnings Call Transcript